Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: A cohort analysis

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  van Cutsem, Gilles ^a,b   Ford, Nathan ^a,b   Hildebrand, Katherine ^a,b   Goemaere, Eric ^a   Mathee, Shaheed ^c   Abrahams, Musaed ^a   Coetzee, David ^b   Boulle, Andrew ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WESTERN CAPE DEPARTMENT OF AGRICULTURE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LOSS TO FOLLOW UP; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREGNANCY; PRIMARY MEDICAL CARE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOUTH AFRICA; ALGORITHM; HEALTH CARE QUALITY; METHODOLOGY; PROBABILITY; REGISTER; STATISTICAL ANALYSIS; STATISTICS;

ADULT; ALGORITHMS; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; PROBABILITY; PROGRAM EVALUATION; REGISTRIES; RESEARCH DESIGN; SOUTH AFRICA;

EID: 79951878920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014684     Document Type: Article

References (31)

1. Rosen S, Fox MP, Gill CJ, (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4: e298 doi:210.1371/journal.pmed.0040298.
2. Brinkhof MW, Pujades-Rodriguez M, Egger M, (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790.
3. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN, (2008) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300: 506-507.
4. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 53: 405-411.
5. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One 3: e1725.
6. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, et al. (2007) Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 21: 965-971.
7. Statistics South Africa (2009) Mortality and causes of death in South Africa, 2007: Findings from death notification. Pretoria Statistics South Africa.
8. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, et al. (2004) Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 18 (Suppl 3): S27-31.
9. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18: 887-895.
10. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24: 563-572.
11. Chi B, Westfall A, Fox M, Phiri S, Prozesky H, et al. (2010) Empirically defining lost to follow-up for antiretroviral therapy programs in southern Africa. Vienna, Austria XVIII International AIDS Conference.
12. Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I, (2010) Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health 4: 405-13.
13. Fox MP, Rosen S, (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 15 (Suppl 1): 1-15.
14. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 85: 550-554.
15. Cornell M, Grimsrud A, Fairall L, Fox MP, Van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy accross South Africa, 2002-2007 AIDS 24: 2263-70.
16. Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, et al. (2010) Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS 24 (17): 2645-50.
17. Jerene D, Endale A, Hailu Y, Lindtjørn B, (2006) Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis 6: 136.
18. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559-567.
19. Fox RC, Goemaere E, (2006) They call it "patient selection" in Khayelitsha: the experience of Medecins Sans Frontieres-South Africa in enrolling patients to receive antiretroviral treatment for HIV/AIDS. Camb Q Healthc Ethics 15: 302-312.
20. Bedelu M, Ford N, Hilderbrand K, Reuter H, (2007) Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis 196 (Suppl 3): S464-468.
21. Zachariah R, Van Engelgem I, Massaquoi M, Kocholla L, Manzi M, et al. (2008) Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Trans R Soc Trop Med Hyg 102: 288-293.
22. Maskew M, MacPhail P, Menezes C, Rubel D, (2007) Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J 97: 853-857.
23. Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK, (2008) Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Trop Med Int Health 13: 328-333.
24. Losina E, Toure H, Uhler LM, Anglaret X, Paltiel AD, et al. (2009) Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal. PLoS Med 6: e1000173.
25. Nachega JB, Mills EJ, Schechter M, (2010) Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS 5: 70-77.
26. World Health Organisation (2009) Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva World Health Organisation.
27. National Department of Health South Africa (2010) Clinical guidelines for the management of HIV & AIDS in adults and adolescents. In: National Department of Health SA, editor.
28. Kaplan R, Orrell C, Zwane E, Bekker LG, Wood R, (2008) Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22: 1679-1681.
29. Kranzer K, Lewis J, Ford N, Pitt J, Orrell C. et al, (2010) Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors. J Acquir Immune Defic Syndr 55 (3): e17-23.
30. Ingle S, May M, Uebel K, Timmerman V, Kotze E, et al. (2010) Outcomes in patient waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS 24 (17): 2717-25.
31. Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, et al. (2009) Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr 52: 397-405.